{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:14:19Z","timestamp":1781075659028,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jiac.2021.08.016","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T19:48:17Z","timestamp":1629143297000},"page":"1716-1722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical evaluation of QuantiFERON\u00ae-TB Gold Plus directly compared with QuantiFERON\u00ae-TB Gold In-Tube and T-Spot\u00ae.TB for active pulmonary tuberculosis in the elderly"],"prefix":"10.1016","volume":"27","author":[{"given":"Kiyoyasu","family":"Fukushima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5487-0453","authenticated-orcid":false,"given":"Kazumasa","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuko","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Ehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Takazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7577-476X","authenticated-orcid":false,"given":"Noriho","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2021.08.016_bib1","author":"World Health Organization"},{"key":"10.1016\/j.jiac.2021.08.016_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40249-019-0614-9","article-title":"Incidence and risk factors of tuberculosis among the elderly population in China: a prospective cohort study","volume":"9","author":"Cheng","year":"2020","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.jiac.2021.08.016_bib3","first-page":"751","article-title":"Tuberculosis in the global aging population","volume":"24","author":"Mori","year":"2010","journal-title":"Infect Dis Clin"},{"key":"10.1016\/j.jiac.2021.08.016_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/resp.13303","article-title":"Epidemiological, clinical and mechanistic perspectives of tuberculosis in older people","volume":"23","author":"Yew","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.jiac.2021.08.016_bib5","volume":"2","author":"Pai","year":"2016","journal-title":"Tuberculosis. Nat Rev Dis Primers"},{"key":"10.1016\/j.jiac.2021.08.016_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00021-18","article-title":"Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection","volume":"31","author":"Drain","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2021.08.016_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1164\/rccm.202006-2394PP","article-title":"The epidemiological importance of subclinical tuberculosis. A critical reappraisal","volume":"203","author":"Kendall","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2021.08.016_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2021.08.016_bib9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1586\/erm.11.46","article-title":"TB assay usage in adults and children","volume":"11","author":"Soysal","year":"2011","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jiac.2021.08.016_bib10","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3389\/fimmu.2020.02006","article-title":"Diagnosis for latent tuberculosis infection: new alternatives","volume":"11","author":"Carranza","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiac.2021.08.016_bib11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4046\/trd.2012.72.5.416","article-title":"Factors associated with indeterminate and false negative results of quantiferon-tb gold in-tube test in active tuberculosis","volume":"72","author":"Cho","year":"2012","journal-title":"Tuberc Respir Dis"},{"key":"10.1016\/j.jiac.2021.08.016_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1183\/09031936.00120214","article-title":"False-negative interferon-gamma release assay results in active tuberculosis: a TBNET study","volume":"45","author":"de Visser","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2021.08.016_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023806","article-title":"Analysis of factors lowering sensitivity of interferon-gamma release assay for tuberculosis","volume":"6","author":"Hang","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2021.08.016_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129792","article-title":"Factors that predict negative results of QuantiFERON-TB Gold In-Tube test in patients with culture-confirmed tuberculosis: a multicenter retrospective cohort study","volume":"10","author":"Kwon","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2021.08.016_bib15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1186\/s12879-019-4310-y","article-title":"Quantitative investigation of factors relevant to the T cell spot test for tuberculosis infection in active tuberculosis","volume":"19","author":"Li","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2021.08.016_bib16","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41598-020-58459-9","article-title":"Factors associated with false negative interferon-gamma release assay results in patients with tuberculosis: a systematic review with meta-analysis","volume":"10","author":"Yamasue","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2021.08.016_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tube.2017.06.002","article-title":"Analytical evaluation of QuantiFERON- plus and QuantiFERON- gold in-tube assays in subjects with or without tuberculosis","volume":"106","author":"Petruccioli","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jiac.2021.08.016_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jiac.2017.10.009","article-title":"Sensitivity and specificity of QuantiFERON-TB gold plus compared with QuantiFERON-TB gold in-tube and T-SPOT.TB on active tuberculosis in Japan","volume":"24","author":"Takasaki","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.08.016_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/srep30617","article-title":"Evaluation of QuantiFERON-TB gold plus for detection of mycobacterium tuberculosis infection in Japan","volume":"6","author":"Yi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2021.08.016_bib20","series-title":"ELISA package insert","year":"2016"},{"key":"10.1016\/j.jiac.2021.08.016_bib21","series-title":"QuantiFERON\u00ae-TB Gold plus (QFT\u00ae-Plus) package insert","author":"Qiagen","year":"2019"},{"key":"10.1016\/j.jiac.2021.08.016_bib22","series-title":"Oxford Immunotec. T-SPOT","year":"2016"},{"key":"10.1016\/j.jiac.2021.08.016_bib23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jinf.2019.08.018","article-title":"QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis","volume":"79","author":"Sotgiu","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2021.08.016_bib24","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5588\/ijtld.16.0764","article-title":"The sensitivity of the QuantiFERON((R))-TB Gold Plus assay in Zambian adults with active tuberculosis","volume":"21","author":"Telisinghe","year":"2017","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2021.08.016_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jiac.2017.09.012","article-title":"Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis","volume":"24","author":"Igari","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.08.016_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ni1033","article-title":"Age-related changes in lymphocyte development and function","volume":"5","author":"Linton","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jiac.2021.08.016_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1385\/IR:22:2-3:253","article-title":"The human thymus during aging","volume":"22","author":"Haynes","year":"2000","journal-title":"Immunol Res"},{"key":"10.1016\/j.jiac.2021.08.016_bib28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.exger.2017.10.024","article-title":"Age and immunity: what is \"immunosenescence\"?","volume":"105","author":"Pawelec","year":"2018","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jiac.2021.08.016_bib29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000199451","article-title":"Reference values for CD4+ and CD8+ T lymphocytes with naive or memory phenotype and their association with mortality in the elderly","volume":"55","author":"Provinciali","year":"2009","journal-title":"Gerontology"},{"key":"10.1016\/j.jiac.2021.08.016_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00272-20","article-title":"Accuracy of QuantiFERON-TB Gold Plus test for diagnosis of mycobacterium tuberculosis infection in children","volume":"58","author":"Buonsenso","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2021.08.016_bib31","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4269\/ajtmh.18-0674","article-title":"Evaluation of the QuantiFERON-Tuberculosis Gold Plus assay in children with tuberculosis disease or following household exposure to tuberculosis","volume":"100","author":"Kay","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jiac.2021.08.016_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01950-19","article-title":"Fourth-generation QuantiFERON-TB gold plus: what is the evidence?","volume":"58","author":"Shafeque","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2021.08.016_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00985-19","article-title":"Comparing QuantiFERON-TB Gold Plus with other tests to diagnose mycobacterium tuberculosis infection","volume":"57","author":"Venkatappa","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2021.08.016_bib34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.resinv.2019.07.002","article-title":"Variation in interferon-gamma production between QFT-Plus and QFT-GIT assays in TB contact investigation","volume":"57","author":"Tsuyuzaki","year":"2019","journal-title":"Respir Investig"},{"key":"10.1016\/j.jiac.2021.08.016_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00427-18","article-title":"QuantiFERON-TB Gold Plus Is a more sensitive screening tool than QuantiFERON-TB Gold in-tube for latent tuberculosis infection among older adults in long-term care facilities","volume":"56","author":"Chien","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2021.08.016_bib36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jiac.2019.02.018","article-title":"Positivity rate of interferon-gamma release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan","volume":"25","author":"Igari","year":"2019","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.08.016_bib37","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jiac.2020.11.012","article-title":"Prevalence of positive IGRAs and innate immune system in HIVinfected individuals in Japan","volume":"27","author":"Igari","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.08.016_bib38","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening","volume":"48","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2021.08.016_bib39","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tube.2017.11.014","article-title":"A multicentre verification study of the QuantiFERON((R))-TB Gold Plus assay","volume":"108","author":"Pieterman","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jiac.2021.08.016_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tube.2018.10.014","article-title":"Characterization of specific CD4 and CD8 T-cell responses in QuantiFERON TB Gold-Plus TB1 and TB2 tubes","volume":"113","author":"Allen","year":"2018","journal-title":"Tuberculosis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21002348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21002348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:02:19Z","timestamp":1761159739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21002348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1341321X21002348"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.08.016","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical evaluation of QuantiFERON\u00ae-TB Gold Plus directly compared with QuantiFERON\u00ae-TB Gold In-Tube and T-Spot\u00ae.TB for active pulmonary tuberculosis in the elderly","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}